Inflammation & Allergy - Drug Targets (Discontinued)
Title:Meet Our Editor:
Volume: 14 Issue: 1
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
Zaenker S. Kurt, Meet Our Editor:, Inflammation & Allergy - Drug Targets (Discontinued) 2015; 14 (1) . https://dx.doi.org/10.2174/187152811401151211113118
DOI https://dx.doi.org/10.2174/187152811401151211113118 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
18
Related Articles
-
Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies
Current Medicinal Chemistry Helicobacter Pylori and Inflammation
Current Pharmaceutical Design Brain Injury Associated with Widely Abused Amphetamines: Neuroinflammation, Neurogenesis and Blood-Brain Barrier
Current Drug Abuse Reviews Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy
Current Cancer Therapy Reviews Validated Stability-indicating RP-HPLC Method for the Determination of Parecoxib Sodium and Degradation Impurities in Bulk Drug
Current Pharmaceutical Analysis Genetic Engineering of Allergens for Immunotherapy
Inflammation & Allergy - Drug Targets (Discontinued) Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders
CNS & Neurological Disorders - Drug Targets Probiotics Against Viruses; COVID-19 is a Paper Tiger: A Systematic Review
Endocrine, Metabolic & Immune Disorders - Drug Targets EDITORIAL (Hot Topic: Beyond Reproductive Effects of Sex Steroids)
Mini-Reviews in Medicinal Chemistry Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment
Current Cancer Drug Targets Inflammation Fuels Tumor Progress and Metastasis
Current Pharmaceutical Design Novel Therapeutic Approaches and Treatment Targets for Psoriatic Arthritis
Current Pharmaceutical Biotechnology Benzimidazoles: An Ideal Privileged Drug Scaffold for the Design of Multitargeted Anti-inflammatory Ligands
Mini-Reviews in Medicinal Chemistry Advances and Patents about Grinding Equipments with Nano-Particle Jet Minimum Quantity Lubrication
Recent Patents on Nanotechnology Perinatal Brain Injury
Current Pediatric Reviews Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect
Current Drug Discovery Technologies Regulation of Cytokine Production by γδ T Cells
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
CNS & Neurological Disorders - Drug Targets <i>In vitro</i> and Molecular Docking Analysis of Quercetin as an Anti-inflammatory and Antioxidant
Current Pharmaceutical Design The Nuclear Orphan Receptor NR4A1 and NR4A3 as Tumor Suppressors in Hematologic Neoplasms
Current Drug Targets